News and Announcements
MPSS Enters Into Contract For Acquisition #1
- Published August 11, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
MPSS is proud to announce the strategic plan to add scale via selected acquisition targets currently underway. The company has reached an agreement and will enter into a contract to acquire target number 1 under our scale-up plan. We anticipate that the income stream secured via this acquisition will flow from late September this year.
Furthermore, MPSS is on track to exchange EOI with our 2nd scale-up target by mid to late August 2022. The additional rent collection cash to flow from these two scale-up acquisitions will effectively double MPSS’s regular monthly income.
Due to excess capacity, MPSS is adding pure income via the completion of purchases with target 1 and is acquiring target 2 with the addition of only one existing employee. Both targets will be absorbed into MPSS existing operations and will not incur additional costs such as additional office rent and new infrastructure.
MPSS is moving ahead and we look forward to meeting with investors at the V&C conference in Singapore and discussing our unique investment opportunity which can provide investors with options to access real estate ownership directly.
Company Updates
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t
The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.
The Life Sciences Supercycle: Why Australian Biotech is Finally Delivering Billion-Dollar Outcomes
Australia’s life sciences sector is experiencing an unprecedented “Supercycle,” finally commercializing world-class research into global, billion-dollar businesses. Learn about the ASX heavyweights, the key drivers (AI, institutional execution, FDA pathway), and the investment opportunity at Emergence 2026.
Following the Billions: Where the Hyperscalers are Betting on the Future
The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.
Backed By Leading Investment Groups and Family Offices
